Contact
searchSearch
HMP Global

November 2015 - FRMC

Conference Insider
AMCP: Qualified Health Plans: Ratings, Restrictions, and Requirements for 2016 and Beyond
12/21/2015
Alessia D'Anna
CMS submitted its letter outlining the 2016 prescription drug requirements to insurers in the federally facilitated marketplace.
CMS submitted its letter outlining the 2016 prescription drug requirements to insurers in the federally facilitated marketplace.
CMS submitted its letter...
12/21/2015
First Report Managed Care
Literature Review: Hyperkalemia
12/18/2015
  New Treatment for Hyperkalemia Current therapy options are limited and there is an increased risk of drug–drug interactions when patients take >1 potassium increasing drug. Hyperkalemia is defined as elevated serum potassium...
  New Treatment for Hyperkalemia Current therapy options are limited and there is an increased risk of drug–drug interactions when patients take >1 potassium increasing drug. Hyperkalemia is defined as elevated serum potassium...
  New Treatment for...
12/18/2015
First Report Managed Care
MANAGING ASTHMA: Keys to Delivering Value-Based Care
12/16/2015
Asthma can be difficult to treat, making it a challenge to manage in a value-based framework.  
Asthma can be difficult to treat, making it a challenge to manage in a value-based framework.  
Asthma can be difficult to...
12/16/2015
First Report Managed Care
Department
Disease State Overview: MANAGING ASTHMA: Keys to Delivering Value-Based Care
12/16/2015
MANAGING ASTHMA: Keys to Delivering Value-Based Care Asthma can be difficult to treat, making it a challenge to manage in a value-based framework.  
MANAGING ASTHMA: Keys to Delivering Value-Based Care Asthma can be difficult to treat, making it a challenge to manage in a value-based framework.  
MANAGING ASTHMA: Keys to...
12/16/2015
First Report Managed Care
Department
Literature Review: Psoriasis Carries Hefty Price Tag
12/16/2015
Costs associated with psoriasis may be viewed from several different perspectives, including the patient, payer, and society.  
Costs associated with psoriasis may be viewed from several different perspectives, including the patient, payer, and society.  
Costs associated with psoriasis...
12/16/2015
First Report Managed Care
Burden of Antibiotic Resistance: Stopping an Epidemic, Containing Cost
12/16/2015
Stephanie Vaccaro
Burden of Antibiotic Resistance: Stopping an Epidemic, Containing Cost​ Antibiotic resistance is exacting a high price in the US. In April 2011, the Centers for Dis­ease Control (CDC) reported that antibiotic resistance accounted for...
Burden of Antibiotic Resistance: Stopping an Epidemic, Containing Cost​ Antibiotic resistance is exacting a high price in the US. In April 2011, the Centers for Dis­ease Control (CDC) reported that antibiotic resistance accounted for...
Burden of Antibiotic Resistance:...
12/16/2015
First Report Managed Care
Conference Insider
PCMH: Systematizing Patient-Centered Medical Home Transformation
12/16/2015
Systematizing Patient-Centered Medical Home Transformation With the rise of patient-centered medical homes (PCMHs) and accountable care organizations (ACOs), it is important for managed care professionals to understand how these models can...
Systematizing Patient-Centered Medical Home Transformation With the rise of patient-centered medical homes (PCMHs) and accountable care organizations (ACOs), it is important for managed care professionals to understand how these models can...
Systematizing Patient-Centered...
12/16/2015
First Report Managed Care
Conference Insider
ECTRIMS: Impact of Impaired Walking On Health Care Utilization
12/16/2015
Impaired mobility and walking in patients with multiple sclerosis (MS) negatively impacts all aspects of the patients’ lives.
Impaired mobility and walking in patients with multiple sclerosis (MS) negatively impacts all aspects of the patients’ lives.
Impaired mobility and walking in...
12/16/2015
First Report Managed Care
Conference Insider
ECTRIMS: EMERALD Shows High Compliance Rate With Alemtuzumab
12/16/2015
Interim analysis from the ongoing EMERALD [Evaluation of the Management of Infusion Reactions in Alemtuzumab- treated Patients] study will help provide additional guidance for optimizing the management of infusion-associated reactions (IARs)...
Interim analysis from the ongoing EMERALD [Evaluation of the Management of Infusion Reactions in Alemtuzumab- treated Patients] study will help provide additional guidance for optimizing the management of infusion-associated reactions (IARs)...
Interim analysis from the...
12/16/2015
First Report Managed Care
Conference Insider
ECTRIMS: Overcoming Uncertainty When Managing MS Relapse
12/16/2015
Relapses are one of the dis­tinctive features of relapsing-remitting multiple sclerosis (MS) and serve as the defining clinical presentation that leads to diagnosis and delivery of value-based care. There is uncertainty and het­erogeneity in...
Relapses are one of the dis­tinctive features of relapsing-remitting multiple sclerosis (MS) and serve as the defining clinical presentation that leads to diagnosis and delivery of value-based care. There is uncertainty and het­erogeneity in...
Relapses are one of the...
12/16/2015
First Report Managed Care
AMCP: Are You Armed to Succeed with Biosimilars?
12/16/2015
The introduction of biosimilars could mean reductions in health care costs; however, education and preparation will be required for their successful use.
The introduction of biosimilars could mean reductions in health care costs; however, education and preparation will be required for their successful use.
The introduction of biosimilars...
12/16/2015
First Report Managed Care
How to Build a Value Assessment Model
12/16/2015
Melissa D. Cooper
Determining the vale of a drug may require less data than you realize
Determining the vale of a drug may require less data than you realize
Determining the vale of a drug...
12/16/2015
First Report Managed Care
AMCP: The Impact of Orphan Drugs on Rare Diseases: Growth, Spending, and Treatment Options
12/16/2015
NULL
NULL
 The status of orphan drug develop­ment in 2 rare disease states—as well as key manage­ment strategies—were addressed by 2 experts during AMCP Nexus 2015. Rare diseases are exceptionally diverse. “The only thing in common [between] them is...
 The status of orphan drug develop­ment in 2 rare disease states—as well as key manage­ment strategies—were addressed by 2 experts during AMCP Nexus 2015. Rare diseases are exceptionally diverse. “The only thing in common [between] them is...
 The status of orphan drug...
12/16/2015
First Report Managed Care
Specialty Pharma: The Good, the Bad, and the Challenging
12/16/2015
Melissa D. Cooper
Specialty Pharma: The Good, the Bad, and the Challenging The rising cost of specialty pharmaceuticals is a critical issue among managed care professionals.  
Specialty Pharma: The Good, the Bad, and the Challenging The rising cost of specialty pharmaceuticals is a critical issue among managed care professionals.  
Specialty Pharma: The Good, the...
12/16/2015
First Report Managed Care

Behind the Bill

Behind the Bill
The Senate’s $3 Trillion Deal. Tax Relief Now, Medicaid Coverage Loss Later?
07/02/2025
Katie Hayes, MJ
The Senate has done it. After weeks of behind-the-scenes wrangling and last-minute amendments, lawmakers have passed a sprawling tax-and-spending megabill that makes good on a long-standing Republican goal: making the 2017 Trump tax cuts...
The Senate has done it. After weeks of behind-the-scenes wrangling and last-minute amendments, lawmakers have passed a sprawling tax-and-spending megabill that makes good on a long-standing Republican goal: making the 2017 Trump tax cuts...
The Senate has done it. After...
07/02/2025
First Report Managed Care
Behind the Bill
When a Cap Isn’t Just a Cap: How a Provider Tax Proposal Could Reshape Medicaid Financing
06/25/2025
Katie Hayes, MJ
In Washington, the most consequential policies are often buried in the fine print. One such detail in the Senate Finance Committee’s latest tax and spending proposal would gradually cap provider taxes—a core funding tool states use to pull in...
In Washington, the most consequential policies are often buried in the fine print. One such detail in the Senate Finance Committee’s latest tax and spending proposal would gradually cap provider taxes—a core funding tool states use to pull in...
In Washington, the most...
06/25/2025
First Report Managed Care
Behind the Bill
Rewriting the Safety Net? Inside the Senate’s Changes to Medicaid and the ACA
06/18/2025
Katie Hayes, MJ
Over the past few weeks, I’ve been following the progress of the One Big Beautiful Bill Act (OBBBA), which started in the House with sweeping tax reforms and some eye-catching health care proposals. Now, the Senate has released its (highly...
Over the past few weeks, I’ve been following the progress of the One Big Beautiful Bill Act (OBBBA), which started in the House with sweeping tax reforms and some eye-catching health care proposals. Now, the Senate has released its (highly...
Over the past few weeks, I’ve...
06/18/2025
First Report Managed Care
Behind the Bill
How States Might Respond to the One Big Beautiful Bill Act
06/11/2025
Katie Hayes, MJ
With the One Big Beautiful Bill Act (OBBBA) still in the hands of the Senate, much of the national conversation has centered on what this legislation would do to federal coverage programs. But regardless of how the federal process unfolds,...
With the One Big Beautiful Bill Act (OBBBA) still in the hands of the Senate, much of the national conversation has centered on what this legislation would do to federal coverage programs. But regardless of how the federal process unfolds,...
With the One Big Beautiful Bill...
06/11/2025
First Report Managed Care
Behind the Bill
Is the Affordable Care Act on the Chopping Block? What the One Big Beautiful Bill Act Tells Us.
06/04/2025
Katie Hayes, MJ
It’s been weeks of headline-grabbing debate over Medicaid work requirements, and the “One Big Beautiful Bill Act” remains in the Senate as they deliberate over several health care provisions. While the Medicaid provisions sparked most of the...
It’s been weeks of headline-grabbing debate over Medicaid work requirements, and the “One Big Beautiful Bill Act” remains in the Senate as they deliberate over several health care provisions. While the Medicaid provisions sparked most of the...
It’s been weeks of...
06/04/2025
First Report Managed Care
Behind the Bill
From House to Senate: The Journey of Cutting Medicaid
05/28/2025
Katie Hayes, MJ
Last week, the House of Representatives narrowly passed the One Big Beautiful Bill Act (HR 1, 119th Congress) by a single vote, sending the sweeping tax and spending reconciliation package, backed by President Trump, to the Senate. With its...
Last week, the House of Representatives narrowly passed the One Big Beautiful Bill Act (HR 1, 119th Congress) by a single vote, sending the sweeping tax and spending reconciliation package, backed by President Trump, to the Senate. With its...
Last week, the House of...
05/28/2025
First Report Managed Care
Behind the Bill
Eligibility, Paperwork, and Penalties: The Not-So-Hidden Costs of Medicaid ‘Reform’
05/21/2025
Katie Hayes, MJ
It’s been another eventful week in health policy—a phrase that’s quickly becoming routine. This time, House Republicans advanced a sweeping budget reconciliation bill, designed to implement elements of the March budget resolution, with a...
It’s been another eventful week in health policy—a phrase that’s quickly becoming routine. This time, House Republicans advanced a sweeping budget reconciliation bill, designed to implement elements of the March budget resolution, with a...
It’s been another eventful week...
05/21/2025
First Report Managed Care
Behind the Bill
A Busy Week in Drug Pricing Policy: Aligning US Drug Prices With Global Standards?
05/14/2025
Katie Hayes, MJ
It’s been a busy few days for drug pricing policy. While I’d love to dig into the details of both President Trump’s latest executive order and the newest Republican bill that would cut Medicaid spending, we don’t have the time—and this isn’t...
It’s been a busy few days for drug pricing policy. While I’d love to dig into the details of both President Trump’s latest executive order and the newest Republican bill that would cut Medicaid spending, we don’t have the time—and this isn’t...
It’s been a busy few days for...
05/14/2025
First Report Managed Care
BEHIND THE BILL
When Agencies Lose Power: How 3 Seismic Shifts are Transforming Pharmaceutical Regulation
05/07/2025
Katie Hayes, MJ
In the span of just 9 months, the landscape of administrative law has undergone a transformation so profound that pharmaceutical executives, health care providers, and patients alike are struggling to navigate the new terrain. The Supreme...
In the span of just 9 months, the landscape of administrative law has undergone a transformation so profound that pharmaceutical executives, health care providers, and patients alike are struggling to navigate the new terrain. The Supreme...
In the span of just 9 months,...
05/07/2025
First Report Managed Care
Behind the Bill
The Medicare Paradox, Part 3: Strategic Trade Doesn’t Have to be a Zero-Sum Game
05/07/2025
Katie Hayes, MJ
Over the past 2 weeks, I’ve examined the growing friction between the Section 232 pharmaceutical tariff investigations and the Medicare drug pricing reforms authorized by the Inflation Reduction Act (IRA). These 2 policy agendas—industrial...
Over the past 2 weeks, I’ve examined the growing friction between the Section 232 pharmaceutical tariff investigations and the Medicare drug pricing reforms authorized by the Inflation Reduction Act (IRA). These 2 policy agendas—industrial...
Over the past 2 weeks, I’ve...
05/07/2025
First Report Managed Care

Trending Articles

News
Comparative Effectiveness for Bronchodilator Responsiveness Testing
02/09/2024
Emry Lloyd
A new study compares the efficacy of salbutamol administration via a nebulizer vs a metered-dose inhaler with a spacer for bronchodilator responsiveness testing.
A new study compares the efficacy of salbutamol administration via a nebulizer vs a metered-dose inhaler with a spacer for bronchodilator responsiveness testing.
A new study compares the...
02/09/2024
First Report Managed Care
News
Trial to Test CAR T-Cell Therapy for Refractory Progressive MS
03/18/2024
Jolynn Tumolo
An autologous, fully human CD19 chimeric antigen receptor (CAR) T-cell product candidate recently received clearance from the US Food and Drug Administration (FDA) as an investigational new drug for the treatment of patients with refractory...
An autologous, fully human CD19 chimeric antigen receptor (CAR) T-cell product candidate recently received clearance from the US Food and Drug Administration (FDA) as an investigational new drug for the treatment of patients with refractory...
An autologous, fully human CD19...
03/18/2024
First Report Managed Care
Conference Coverage
PBM Legislation: Navigating Congressional Delays and Encouraging Progress
04/17/2024
Hannah Musick
Explore the world of federal pharmacy benefit manager (PBM) legislation and its potential impact on stakeholders in this in-depth analysis presented by Ross Margulies, JD, MPH, Partner and Co-Chair Healthcare and Life Sciences Coverage &...
Explore the world of federal pharmacy benefit manager (PBM) legislation and its potential impact on stakeholders in this in-depth analysis presented by Ross Margulies, JD, MPH, Partner and Co-Chair Healthcare and Life Sciences Coverage &...
Explore the world of federal...
04/17/2024
First Report Managed Care
Conference Coverage
The Impact of Fatigue on Prospective Memory in Persons With MS
05/23/2024
Hannah Musick
High fatigue levels in persons with multiple sclerosis (MS) are significantly associated with subjective impairment in prospective memory, particularly in tasks such as forgetting the date and missing appointments.
High fatigue levels in persons with multiple sclerosis (MS) are significantly associated with subjective impairment in prospective memory, particularly in tasks such as forgetting the date and missing appointments.
High fatigue levels in persons...
05/23/2024
First Report Managed Care
Interview
Enhancing Patient Services: Payer and Provider Considerations
06/28/2024
Patient services emerged as a central topic at AXS24, with many stakeholders emphasizing the need for consistency and accessibility in patient support. They also highlighted the importance of addressing both financial and emotional support...
Patient services emerged as a central topic at AXS24, with many stakeholders emphasizing the need for consistency and accessibility in patient support. They also highlighted the importance of addressing both financial and emotional support...
Patient services emerged as a...
06/28/2024
First Report Managed Care

December 2015 Volume 12 Issue 11

View Issue Archive
Editorial Correspondence

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use